Literature DB >> 33140167

CRISPR-Cas adaptive immune systems in Sulfolobales: genetic studies and molecular mechanisms.

Zhenxiao Yu1, Suping Jiang1,2, Yuan Wang1,2, Xuhui Tian1,2, Pengpeng Zhao1, Jianan Xu1, Mingxia Feng1, Qunxin She3.   

Abstract

CRISPR-Cas systems provide the small RNA-based adaptive immunity to defend against invasive genetic elements in archaea and bacteria. Organisms of Sulfolobales, an order of thermophilic acidophiles belonging to the Crenarchaeotal Phylum, usually contain both type I and type III CRISPR-Cas systems. Two species, Saccharolobus solfataricus and Sulfolobus islandicus, have been important models for CRISPR study in archaea, and knowledge obtained from these studies has greatly expanded our understanding of molecular mechanisms of antiviral defense in all three steps: adaptation, expression and crRNA processing, and interference. Four subtypes of CRISPR-Cas systems are common in these organisms, including I-A, I-D, III-B, and III-D. These cas genes form functional modules, e.g., all genes required for adaptation and for interference in the I-A immune system are clustered together to form aCas and iCas modules. Genetic assays have been developed to study mechanisms of adaptation and interference by different CRISPR-Cas systems in these model archaea, and these methodologies are useful in demonstration of the protospacer-adjacent motif (PAM)-dependent DNA interference by I-A interference modules and multiple interference activities by III-B Cmr systems. Ribonucleoprotein effector complexes have been isolated for Sulfolobales III-B and III-D systems, and their biochemical characterization has greatly enriched the knowledge of molecular mechanisms of these novel antiviral immune responses.

Entities:  

Keywords:  CRISPR-Cas; PAM-dependent DNA interference; RNA-activated Cas10 activities; Sulfolobales; adaptation; anti-CRISPR; cOA signaling; crRNA processing; spatiotemporal regulation

Mesh:

Substances:

Year:  2020        PMID: 33140167     DOI: 10.1007/s11427-020-1745-0

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  141 in total

1.  Production of recombinant and tagged proteins in the hyperthermophilic archaeon Sulfolobus solfataricus.

Authors:  S-V Albers; M Jonuscheit; S Dinkelaker; T Urich; A Kletzin; R Tampé; A J M Driessen; C Schleper
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

3.  Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4.

Authors:  Christian Benda; Judith Ebert; Richard A Scheltema; Herbert B Schiller; Marc Baumgärtner; Fabien Bonneau; Matthias Mann; Elena Conti
Journal:  Mol Cell       Date:  2014-10-02       Impact factor: 17.970

4.  Inhibition of Type III CRISPR-Cas Immunity by an Archaeal Virus-Encoded Anti-CRISPR Protein.

Authors:  Yuvaraj Bhoobalan-Chitty; Thomas Baek Johansen; Nadia Di Cianni; Xu Peng
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

5.  Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.

Authors:  Alexander Bolotin; Benoit Quinquis; Alexei Sorokin; S Dusko Ehrlich
Journal:  Microbiology       Date:  2005-08       Impact factor: 2.777

6.  Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors:  Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

7.  Ring nucleases deactivate type III CRISPR ribonucleases by degrading cyclic oligoadenylate.

Authors:  Januka S Athukoralage; Christophe Rouillon; Shirley Graham; Sabine Grüschow; Malcolm F White
Journal:  Nature       Date:  2018-09-19       Impact factor: 49.962

8.  CRISPRstrand: predicting repeat orientations to determine the crRNA-encoding strand at CRISPR loci.

Authors:  Omer S Alkhnbashi; Fabrizio Costa; Shiraz A Shah; Roger A Garrett; Sita J Saunders; Rolf Backofen
Journal:  Bioinformatics       Date:  2014-09-01       Impact factor: 6.937

9.  Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.

Authors:  Joe Bondy-Denomy; April Pawluk; Karen L Maxwell; Alan R Davidson
Journal:  Nature       Date:  2012-12-16       Impact factor: 49.962

10.  An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity.

Authors:  Januka S Athukoralage; Stephen A McMahon; Changyi Zhang; Sabine Grüschow; Shirley Graham; Mart Krupovic; Rachel J Whitaker; Tracey M Gloster; Malcolm F White
Journal:  Nature       Date:  2020-01-15       Impact factor: 69.504

View more
  2 in total

1.  Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.

Authors:  Pengjun Xia; Anirudha Dutta; Kushol Gupta; Mona Batish; Vijay Parashar
Journal:  J Biol Chem       Date:  2022-01-14       Impact factor: 5.157

2.  Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in Saccharolobus islandicus.

Authors:  Yan Zhang; Jinzhong Lin; Xuhui Tian; Yuan Wang; Ruiliang Zhao; Chenwei Wu; Xiaoning Wang; Pengpeng Zhao; Xiaonan Bi; Zhenxiao Yu; Wenyuan Han; Nan Peng; Yun Xiang Liang; Qunxin She
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.